Join Telegram
LIVE09 Nov 2026, 01:35 AM IST
Home / IPO / Accretion Nutraveda
LISTEDSME

Accretion Nutraveda IPO

Open 28th Jan 2026 · Close 30th Jan 2026 · Listing 4th Feb 2026

Verified 2026-10-0694% data coverage
Issue Price₹129.00
Listing Price₹191.00
Current Price—
Listing Gain48.06%
Current Return—

At a glance

Updated 2026-10-06

The shares listed at ₹191.00, a 48.06% move from the issue price. Accretion Nutraveda is a SME IPO with an issue size of ₹24.77 crore, proposed for listing on BSE SME. The offer opens on 28th Jan 2026 and closes on 30th Jan 2026. The issue structure includes a fresh issue of ₹23.53 crore. The current listing schedule points to 4th Feb 2026.

Issue details

Listing atBSE SME
Issue typeBook Build Issue
Issue size₹24.77 Cr
Fresh issue₹23.53 Cr
Face value₹10
Price band₹122.00–₹129.00
Allotment2nd Feb 2026
Listing4th Feb 2026

Listing performance

Full performance ↗
Issue price₹129.00
Listing price₹191.00
Current price—
Listing gain48.06%
Current return—
Price progressionIssue → Listing → Current

Grey market

GMP page ↗
Latest GMP₹68.00
GMP / upper price52.71%
Est. listing₹197.00
GMP is unofficial sentiment data, not an exchange price.

Timeline

Opens28th Jan 2026
Closes30th Jan 2026
Allotment2nd Feb 2026
Refund3rd Feb 2026
Demat3rd Feb 2026
Listing4th Feb 2026

Subscription demand

Full bidding ↗
QIB1.01×
sHNI2.33×
bHNI1.63×
NII / HNI1.63×
Retail2.19×
Total1.83×

Lot size

InvestorLotsSharesAmount
Minimum Bid12000₹258,000

Company

Use of proceeds

ObjectAmount
Purchase of Machineries for Automation in existing Manufacturing unit₹4.22 Cr
Purchase of Machineries for New Manufacturing Setup₹8.03 Cr
Funding working capital requirements of the Company₹5.50 Cr
General Corporate Purposes₹3.69 Cr
Issue Expenses₹3.33 Cr
Total₹24.77 Cr

Financial performance

Year-wise operating scale, profitability and balance-sheet context.
Full financials ↗
Revenue14.07₹ Cr · -12.4% vs prior year
EBITDA3.29₹ Cr · -9.9% vs prior year
PAT2.33₹ Cr · -10.7% vs prior year
Assets16.35₹ Cr · +50.6% vs prior year
Net Worth8.26₹ Cr · +54.4% vs prior year
Borrowing4.43₹ Cr · +14.8% vs prior year
3-year financial trendRevenue / EBITDA / PAT
₹ crore
Year comparisonCompare scale and profitability at a glance
₹ crore

31 Mar 2023

Assets4.06
Total Income3.07
EBITDA0.59
Profit After Tax0.28
NET Worth0.26
Reserves and Surplus-0.10
Total Borrowing1.97

31 Mar 2024

Assets4.64
Total Income5.20
EBITDA1.21
Profit After Tax0.82
NET Worth1.08
Reserves and Surplus0.72
Total Borrowing2.17

31 Mar 2025

Assets10.86
Total Income16.06
EBITDA3.65
Profit After Tax2.61
NET Worth5.35
Reserves and Surplus4.86
Total Borrowing3.86

30 Sep 2025

Assets16.35
Total Income14.07
EBITDA3.29
Profit After Tax2.33
NET Worth8.26
Reserves and Surplus2.95
Total Borrowing4.43

KPIs

KPIMar 31, 2025Sep 30, 2025
ROE81.22%68.54%
ROCE36.98%49.09%
Debt / Equity0.72%0.54%
RoNW48.85%56.50%
PAT Margin16.33%16.59%
EBITDA Margin22.79%23.36%
Price to Book Value8.767.71

Valuation & shareholding

Pre-IPO EPS4.91
Post-IPO EPS6.44
Pre-IPO P/E26.27
Post-IPO P/E20.02
Promoter holding pre100%
Promoter holding post73.48%
Market cap₹93.40 Cr.

Peer comparison

CompanyEPSP/ERoNWNAV
Accretion Nutraveda IPO—35.75 x——
Sat Kartar IPO—20.23 x——
Vaidya Sane IPO—28.29 x——
Walpar Nutritions IPO—64.00 x——

Issue expenses

ExpenseAmount
Purchase of Machineries for Automation in existing Manufacturing unit₹4.22 Cr
Purchase of Machineries for New Manufacturing Setup₹8.03 Cr
Funding working capital requirements of the Company₹5.50 Cr
General Corporate Purposes₹3.69 Cr
Issue Expenses₹3.33 Cr
Total₹24.77 Cr

Registrar & lead managers

Registrar

Kfin Technologies Ltd.

Lead managers

  • Sobhagya Capital Options Pvt.Ltd.

Offer documents

Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-10-06.
IPO UPDATE ALERTS

Track Accretion Nutraveda without missing an update

Register for subscription, GMP, allotment and listing notifications.

Register for IPO Updates →